As President Biden urges Americans to get booster shots to protect themselves against omicron, a new study indicates the Pfizer/BioNTech COVID-19 vaccine is …
As President Biden urges Americans to get booster shots to protect themselves against omicron, a new study indicates the Pfizer/BioNTech COVID-19 vaccine is considerably less effective against the new variant. There are 40 times fewer antibodies in recipients of the Pfizer vaccine to fight omicron than there are for other variants, according to a pre-print study made available Tuesday by researchers at the African Health Research Institute. So far, the omicron variant, detected in at least 19 U.S. states and nearly 50 countries since the Thanksgiving holiday, appears to be much more contagious than the common delta strain but milder in its impact, according to researchers. The omicron variant has more mutations than any other variant, with a total of 50, including 30 on its spike protein, which is the part of the virus targeted by the vaccines.
